Header Logo

Connection

Vignesh Arasu to Female

Back to Details
This is a "connection" page, showing publications Vignesh Arasu has written about Female.
Vignesh Arasu
Connection Strength
0.376
Female
  1. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.074
  2. Response. Radiology. 2013 Feb; 266(2):685-6.
    View in: PubMed
    Score: 0.036
  3. Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology. 2012 Aug; 264(2):371-7.
    View in: PubMed
    Score: 0.035
  4. Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol. 2011 Jun; 18(6):716-21.
    View in: PubMed
    Score: 0.032
  5. Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women. Breast Cancer Res. 2023 08 06; 25(1):92.
    View in: PubMed
    Score: 0.019
  6. Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
    View in: PubMed
    Score: 0.017
  7. Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective. Ann Surg Oncol. 2021 Oct; 28(10):5648-5656.
    View in: PubMed
    Score: 0.016
  8. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
    View in: PubMed
    Score: 0.016
  9. Acute Kidney Injury After CT in Emergency Patients with Chronic Kidney Disease: A Propensity Score-matched Analysis. West J Emerg Med. 2021 Apr 02; 22(3):614-622.
    View in: PubMed
    Score: 0.016
  10. Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography. 2020 06; 6(2):77-85.
    View in: PubMed
    Score: 0.015
  11. Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy. Tomography. 2020 06; 6(2):101-110.
    View in: PubMed
    Score: 0.015
  12. Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer. Tomography. 2020 06; 6(2):216-222.
    View in: PubMed
    Score: 0.015
  13. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL. J Magn Reson Imaging. 2019 12; 50(6):1742-1753.
    View in: PubMed
    Score: 0.014
  14. Sonographic-MRI Correlation After Percutaneous Sampling of Targeted Breast Ultrasound Lesions: Initial Experiences With Limited-Sequence Unenhanced MRI for Postprocedural Clip Localization. AJR Am J Roentgenol. 2018 Apr; 210(4):927-934.
    View in: PubMed
    Score: 0.013
  15. Effect of Background Parenchymal Enhancement on Breast MR Imaging Interpretive Performance in Community-based Practices. Radiology. 2018 03; 286(3):822-829.
    View in: PubMed
    Score: 0.013
  16. Inter-reader Variability in the Use of BI-RADS Descriptors for Suspicious Findings on Diagnostic Mammography: A Multi-institution Study of 10 Academic Radiologists. Acad Radiol. 2017 01; 24(1):60-66.
    View in: PubMed
    Score: 0.012
  17. Lesion morphology on breast MRI affects targeted ultrasound correlation rate. Eur Radiol. 2015 May; 25(5):1279-84.
    View in: PubMed
    Score: 0.010
  18. Qualitative assessment of enhancement in a renal mass: contribution of subtraction CT. J Comput Assist Tomogr. 2012 Jul-Aug; 36(4):381-7.
    View in: PubMed
    Score: 0.009

© 2025 Kaiser Permanente